Good news, another potential indication. It sounds like JCR will foot the bill for the study and MSB still retain the rights in the USA, win-win!
Ann: MSB Expands JCR Partnership To Brain Disease In Newborns, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
-0.010(0.43%) |
Mkt cap ! $2.956B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.39 | $2.27 | $8.090M | 3.476M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 68107 | $2.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.31 | 11283 | 15 |
View Market Depth
| Last trade - 12.33pm 22/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |